RxDoctor Payments Data

Lea El Hage, MD

Internal Medicine · Cleveland, OHNPI 1386088557

Payments from drug & device makers

$122,640in general payments, 2019–2025

Across 8 payments — averaging $15,330 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$123K
  • Lilly USA, LLC$48
  • Ascendis Pharma Endocrinology Inc$18
  • Novo Nordisk$17

What the payments were for

  • Food & beverage$83100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$122,640 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$53,531
Medicare patients
324
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide127$211,507
TrulicityDulaglutide109$179,653
OzempicSemaglutide56$84,864
JardianceEmpagliflozin63$76,700
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$11,806
SynthroidLevothyroxine Sodium122$11,582
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$10,254
Levothyroxine Sodium547$5,911
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$5,060
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic22$2,901
Insulin Lispro Kwikpen U-100Insulin Lispro12$2,268
Armour ThyroidThyroid,pork20$1,678
LevoxylLevothyroxine Sodium27$1,583
Liothyronine Sodium36$1,545
Glimepiride76$1,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$48$391,159236 claims
Novo NordiskOzempic$17$84,86456 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →